Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(3.43) per share which missed the analyst consensus estimate of $(0.28) by 1125 percent. This is a 1391.3 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $1.085 million which beat the analyst consensus estimate of $750.000 thousand by 44.67 percent. This is a 12.15 percent decrease over sales of $1.235 million the same period last year.